Published in Mol Cytogenet on September 07, 2016
Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med (2012) 4.97
Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ (1992) 2.88
Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol (2014) 2.64
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol (2015) 1.96
Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: results from over 1000 consecutive cases. Ultrasound Obstet Gynecol (2013) 1.63
Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol (2007) 1.63
Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol (2013) 1.58
Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem (2013) 1.54
Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn (2013) 1.49
Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature. Ultrasound Obstet Gynecol (2014) 1.48
Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci U S A (2014) 1.46
Application of SNP array for rapid prenatal diagnosis: implementation, genetic counselling and diagnostic flow. Eur J Hum Genet (2011) 1.37
Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn (2013) 1.35
Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol (2011) 1.35
Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med (2014) 1.33
WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res (2013) 1.28
X chromosome loss and ageing. Cytogenet Genome Res (2007) 1.26
Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol (2005) 1.11
Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses. Eur J Hum Genet (2009) 1.09
Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalities. Mol Cytogenet (2012) 1.08
SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn (2013) 1.04
Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. Clin Chem (2015) 1.04
Prenatal diagnosis using array-CGH: a French experience. Eur J Med Genet (2013) 1.02
Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies. Prenat Diagn (2013) 1.01
Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol (2015) 1.00
Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet (2015) 0.95
Phenotypic variability of atypical 22q11.2 deletions not including TBX1. Am J Med Genet A (2012) 0.94
Benefits and burdens of using a SNP array in pregnancies at increased risk for the common aneuploidies. Hum Mutat (2015) 0.93
Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open (2016) 0.93
Prenatal SNP array testing in 1000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVs. Eur J Hum Genet (2015) 0.83
Fetal cardiac defects and increased nuchal translucency thickness: a prospective study. Am J Obstet Gynecol (2004) 0.83
Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study. Am J Obstet Gynecol (2007) 0.82
(Potential) false-negative diagnoses in chorionic villi and a review of the literature. Prenat Diagn (2006) 0.81
Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration. Expert Rev Mol Diagn (2016) 0.81
Whole-genome array as a first-line cytogenetic test in prenatal diagnosis. Ultrasound Obstet Gynecol (2015) 0.80
Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing? Prenat Diagn (2015) 0.80
Nuchal translucency distributions for different chromosomal anomalies in a large unselected population cohort. Prenat Diagn (2015) 0.78
False Negative NIPT Results: Risk Figures for Chromosomes 13, 18 and 21 Based on Chorionic Villi Results in 5967 Cases and Literature Review. PLoS One (2016) 0.78
Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses. Ultrasound Obstet Gynecol (2009) 0.77
SNP array detects chromosome aberrations that we thought do not exist: the first case of an isochromosome Xp (i(X)(p10)). Prenat Diagn (2014) 0.77
Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms. Prenat Diagn (2015) 0.77
Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype. J Matern Fetal Neonatal Med (2016) 0.76
Discordant results between fetal cell-free DNA in maternal plasma and chorionic villus sampling in a first-trimester fetus with increased nuchal translucency and megacystis. Ultrasound Obstet Gynecol (2014) 0.76
Nuchal translucency thickness in the prediction of unbalanced translocations. Prenat Diagn (2014) 0.76
Chromosomal microarray in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol (2015) 0.76
Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray. Eur J Obstet Gynecol Reprod Biol (2015) 0.76
Validation of an Enhanced Version of a Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Test for Detection of Fetal Aneuploidies. Fetal Diagn Ther (2016) 0.76
Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH? Ultrasound Obstet Gynecol (2014) 0.76
Clinical experience of unexpected findings in prenatal array testing. Biomark Med (2016) 0.75